New insights into inflammatory bowel disease / / edited by Samuel Huber.
The incidence of chronic inflammatory and autoimmune diseases is steadily increasing. Inflammatory bowel disease (IBD) is one example of a chronic inflammatory disease, which primarily affects the intestine but may also affect extraintestinal organs. The exact pathogenesis of IBD is currently unknow...
Saved in:
| : | |
|---|---|
| TeilnehmendeR: | |
| Place / Publishing House: | Rijeka, Crotia : : IntechOpen,, [2016] ©2016 |
| Year of Publication: | 2016 |
| Language: | English |
| Physical Description: | 1 online resource (264 pages) :; illustrations |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
993545497704498 |
|---|---|
| ctrlnum |
(CKB)4970000000099215 (NjHacI)994970000000099215 (oapen)https://directory.doabooks.org/handle/20.500.12854/54589 (EXLCZ)994970000000099215 |
| collection |
bib_alma |
| record_format |
marc |
| spelling |
Samuel Huber auth New insights into inflammatory bowel disease / edited by Samuel Huber. IntechOpen 2016 Rijeka, Crotia : IntechOpen, [2016] ©2016 1 online resource (264 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on: online resource; title from PDF information screen (InTech, viewed October 17, 2022). Includes bibliographical references. The incidence of chronic inflammatory and autoimmune diseases is steadily increasing. Inflammatory bowel disease (IBD) is one example of a chronic inflammatory disease, which primarily affects the intestine but may also affect extraintestinal organs. The exact pathogenesis of IBD is currently unknown. However, it is clear that the pathogenesis is complex, involving barrier defects, changes in the intestinal microbiome, and chronic immune activation. This book aims to summarize basic aspects of these complex interactions between barrier function, microbiome, and the immune system. Of note, there is currently no cure for IBD. However, several therapies have evolved in the last years, which are overall able to-at least temporarily-suppress IBD. These therapies and the underlying mechanism are discussed. English Inflammatory bowel diseases. Medicine Hepatology Gastroenterology Health Sciences 953-51-2754-3 Huber, Samuel, editor. |
| language |
English |
| format |
eBook |
| author |
Samuel Huber |
| spellingShingle |
Samuel Huber New insights into inflammatory bowel disease / |
| author_facet |
Samuel Huber Huber, Samuel, |
| author_variant |
s h sh |
| author2 |
Huber, Samuel, |
| author2_variant |
s h sh |
| author2_role |
TeilnehmendeR |
| author_sort |
Samuel Huber |
| title |
New insights into inflammatory bowel disease / |
| title_full |
New insights into inflammatory bowel disease / edited by Samuel Huber. |
| title_fullStr |
New insights into inflammatory bowel disease / edited by Samuel Huber. |
| title_full_unstemmed |
New insights into inflammatory bowel disease / edited by Samuel Huber. |
| title_auth |
New insights into inflammatory bowel disease / |
| title_new |
New insights into inflammatory bowel disease / |
| title_sort |
new insights into inflammatory bowel disease / |
| publisher |
IntechOpen IntechOpen, |
| publishDate |
2016 |
| physical |
1 online resource (264 pages) : illustrations |
| isbn |
953-51-4167-8 953-51-2755-1 953-51-2754-3 |
| callnumber-first |
R - Medicine |
| callnumber-subject |
RC - Internal Medicine |
| callnumber-label |
RC862 |
| callnumber-sort |
RC 3862 I53 N49 42016 |
| illustrated |
Illustrated |
| dewey-hundreds |
600 - Technology |
| dewey-tens |
610 - Medicine & health |
| dewey-ones |
616 - Diseases |
| dewey-full |
616.344 |
| dewey-sort |
3616.344 |
| dewey-raw |
616.344 |
| dewey-search |
616.344 |
| work_keys_str_mv |
AT samuelhuber newinsightsintoinflammatoryboweldisease AT hubersamuel newinsightsintoinflammatoryboweldisease |
| status_str |
n |
| ids_txt_mv |
(CKB)4970000000099215 (NjHacI)994970000000099215 (oapen)https://directory.doabooks.org/handle/20.500.12854/54589 (EXLCZ)994970000000099215 |
| carrierType_str_mv |
cr |
| is_hierarchy_title |
New insights into inflammatory bowel disease / |
| author2_original_writing_str_mv |
noLinkedField |
| _version_ |
1787548850690457601 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01064nam a2200313 i 4500</leader><controlfield tag="001">993545497704498</controlfield><controlfield tag="005">20221018050112.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">221018s2016 ci a ob 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">953-51-4167-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">953-51-2755-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4970000000099215</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994970000000099215</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/54589</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994970000000099215</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC862.I53</subfield><subfield code="b">.N49 2016</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.344</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Samuel Huber</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">New insights into inflammatory bowel disease /</subfield><subfield code="c">edited by Samuel Huber.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">IntechOpen</subfield><subfield code="c">2016</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Rijeka, Crotia :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">[2016]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (264 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on: online resource; title from PDF information screen (InTech, viewed October 17, 2022).</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The incidence of chronic inflammatory and autoimmune diseases is steadily increasing. Inflammatory bowel disease (IBD) is one example of a chronic inflammatory disease, which primarily affects the intestine but may also affect extraintestinal organs. The exact pathogenesis of IBD is currently unknown. However, it is clear that the pathogenesis is complex, involving barrier defects, changes in the intestinal microbiome, and chronic immune activation. This book aims to summarize basic aspects of these complex interactions between barrier function, microbiome, and the immune system. Of note, there is currently no cure for IBD. However, several therapies have evolved in the last years, which are overall able to-at least temporarily-suppress IBD. These therapies and the underlying mechanism are discussed.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Inflammatory bowel diseases.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Hepatology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Gastroenterology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Health Sciences</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">953-51-2754-3</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huber, Samuel,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-02-22 20:06:30 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-04-13 22:04:18 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5351651400004498&Force_direct=true</subfield><subfield code="Z">5351651400004498</subfield><subfield code="b">Available</subfield><subfield code="8">5351651400004498</subfield></datafield></record></collection> |